HelpLine 1-800-298-2436

21st Century Cures Act Passes the House of Representatives

Thursday, December 1, 2016 — Yesterday the US House of Representatives voted to pass the 21st Century Cures Act. LCA strongly supports the 21st Century Cures Act and applaud the bipartisan work that has led to this historic legislation. We consider this a great step towards improving access to health care for all Americans living with lung cancer.

The bill provides $4.8 billion for the National Institutes of Health (NIH) and $500 million for the Food and Drug Administration (FDA). The NIH funding is earmarked as follows: $1.5 billion for the Precision Medicine Initiative, $1.5 billion for the BRAIN Initiative, $1.8 billion for cancer Moonshot and $30 million for an NIH and FDA joint initiative on regenerative therapies.

As the bill moves forward in the Senate, we will fight alongside of broad coalitions to ensure that sufficient federal funding is allocated for cancer research in the FY 2017 Continuing Resolution which Congress will be considering by the end of next week.

As Chairman Brady said upon passage of the bill: “For too long, federal policies have stood in the way of our researchers, innovators, and doctors delivering the care our patients need. Today, with the passage of the Cures Act, we moved one step closer to breaking down those barriers and finding the cures Americans have been desperately hoping for.”